Treatment of travelers' diarrhea

Journal of Travel Medicine

Volumn 8, Issue SUPPL. 2, 2001, Pages s31-s33

  DuPont, Herbert L ^a,b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BICOZAMYCIN; BISMUTH SALICYLATE; COTRIMOXAZOLE; LOPERAMIDE; NEOMYCIN; RIFAXIMIN; STOMACH SECRETION INHIBITOR;

CAMPYLOBACTER; CLINICAL FEATURE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; ESCHERICHIA COLI; FLUID THERAPY; HUMAN; INTESTINE FLORA; SHORT SURVEY; SYMPTOM; TRAVELLER DIARRHEA;

EID: 0035671592     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2001.tb00544.x     Document Type: Short Survey

References (23)

1. Impact of the National Control of Diarrhoeal Diseases Project on infant and child mortality in Dakahlia, Egypt
2. Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea
3. Adverse effect of lomotil therapy in shigellosis
4. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions
5. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent
6. Prevention and treatment of travelers' diarrhea
7. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis: A double blind study with ampicillin and neomycin
8. Therapeutic efficacy of bicyclomycin for shigellosis experimentally induced in Rhesus monkeys
9. Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea
10. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico
11. Fecal leukocytes in diarrheal illness
12. Screening of patients with acute infectious diarrhoea: Evaluation of clinical features, feacal microscopy, and faecal occult blood testing
13. Rifaximin treatment for acute recurrent diarrhea in children with genitourinary disorders
14. Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: A double-blind, randomized, dose-finding multi-centre study
15. The natural history of diverticular disease of the colon: A role for antibiotics in preventing complications? A retrospective study
16. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth
17. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial
18. Rifaximin: A nonabsorbed antimicrobial in the therapy of travelers' diarrhea
19. Rifaximin versus ciprofloxacin for the treatment of travelers' diarrhea: A randomized, double-blind clinical trial
20. A randomized, double-blind, parallel, placebo (PBO)-controlled study
21. In vitro activity and fecal concentration of rifaximin after oral administration
22. Selection of rifampin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin
23. Sensitivity to rifaximin and rifampicin of Mycobacterium tuberculosis isolated from Guinea pigs treated orally with rifaximin